Skip to main content

Advertisement

Log in

Cerebellar ataxia and myeloradiculopathy associated with AP3B2 antibody: a case report and literature review

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Background

AP3B2 is one of the subunits of vesicle coat protein AP3 and is specifically expressed in central nervous system neurons. AP3B2 antibody has been reported in patients with autoimmune cerebellar ataxia and various extracerebellar symptoms. However, there have been few reports on its clinical features and treatment response.

Methods

We report a 47-year-old man with AP3B2 antibody who presented with insidious-onset paresthesia and gait disturbance. His serum and cerebrospinal fluid (CSF) showed reactivity with the cytoplasm of Purkinje cells and granular layer synapses comparable to the reported specific pattern of anti-AP3B2 IgG, and this was confirmed by a cell-based assay. His symptoms improved after the administration of intravenous immunoglobulin, and oral prednisone and mycophenolate mofetil. Extensive examination and long-term follow-up showed no evidence of malignancy. A literature review was included to emphasize the neurological syndrome associated with this rare autoantibody.

Results

Eleven cases with AP3B2 antibody, including our patient, were identified. The diversity of symptoms, including cerebellar and sensory ataxia, paresthesia, and weakness, was in line with the extensive binding of AP3B2 antibody to the spinal cord gray matter, dorsal root ganglia, cerebellar cortex, and nucleus. In the CSF, half of patients had elevated white blood cell counts, increased protein concentrations, or CSF-specific oligoclonal bands. All previous cases had subacute onsets and no improvement was noted after immunotherapy.

Conclusion

Our case indicated that disorders associated with AP3B2 antibody can also start insidiously. Immunotherapy is warranted given the possibility of clinical improvement.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Assoum M, Philippe C, Isidor B, Perrin L, Makrythanasis P, Sondheimer N, Paris C, Douglas J, Lesca G, Antonarakis S, Hamamy H, Jouan T, Duffourd Y, Auvin S, Saunier A, Begtrup A, Nowak C, Chatron N, Ville D, Mireskandari K, Milani P, Jonveaux P, Lemeur G, Milh M, Amamoto M, Kato M, Nakashima M, Miyake N, Matsumoto N, Masri A, Thauvin-Robinet C, Rivière J-B, Faivre L, Thevenon J (2016) Autosomal-recessive mutations in AP3B2, adaptor-related protein complex 3 beta 2 subunit, cause an early-onset epileptic encephalopathy with optic atrophy. Am J Hum Genet 99:1368–1376

    Article  CAS  Google Scholar 

  2. Danglot L, Galli T (2007) What is the function of neuronal AP-3? Biol Cell 99:349–361

    Article  CAS  Google Scholar 

  3. Darnell RB (1996) Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain. Proc Natl Acad Sci USA 93:4529–4536

    Article  CAS  Google Scholar 

  4. Darnell RB, Furneaux HM, Posner JB (1991) Antiserum from a patient with cerebellar degeneration identifies a novel protein in Purkinje cells, cortical neurons, and neuroectodermal tumors. J Neurosci 11:1224–1230

    Article  CAS  Google Scholar 

  5. Ercoli T, Defazio G, Muroni A (2019) Cerebellar syndrome associated with thyroid disorders. Cerebellum 18:932–940

    Article  CAS  Google Scholar 

  6. Evstratova A, Chamberland S, Faundez V, Tóth K (2014) Vesicles derived via AP-3-dependent recycling contribute to asynchronous release and influence information transfer. Nat Commun 5:5530

    Article  CAS  Google Scholar 

  7. Faúndez V, Horng JT, Kelly RB (1998) A function for the AP3 coat complex in synaptic vesicle formation from endosomes. Cell 93:423–432

    Article  Google Scholar 

  8. Hadjivassiliou M, Graus F, Honnorat J, Jarius S, Titulaer M, Manto M, Hoggard N, Sarrigiannis P, Mitoma H (2020) Diagnostic criteria for primary autoimmune cerebellar ataxia-guidelines from an international task force on immune-mediated cerebellar ataxias. Cerebellum 19:605–610

    Article  Google Scholar 

  9. Hadjivassiliou M, Grunewald RA, Shanmugarajah PD, Sarrigiannis PG, Zis P, Skarlatou V, Hoggard N (2020) Treatment of primary autoimmune cerebellar ataxia with mycophenolate. Cerebellum 19:680–684

    Article  CAS  Google Scholar 

  10. Honorat JA, Lopez-Chiriboga AS, Kryzer TJ, Komorowski L, Scharf M, Hinson SR, Lennon VA, Pittock SJ, Klein CJ, McKeon A (2019) Autoimmune gait disturbance accompanying adaptor protein-3B2-IgG. Neurology 93:e954–e963

    Article  Google Scholar 

  11. Jarius S, Wildemann B (2015) ’Medusa head ataxia: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook. J Neuroinflammation 12:168

    Article  CAS  Google Scholar 

  12. Li P, Merrill SA, Jorgensen EM, Shen K (2016) Two clathrin adaptor protein complexes instruct axon-dendrite polarity. Neuron 90:564–580

    Article  CAS  Google Scholar 

  13. Lim DS, Kirsch DG, Canman CE, Ahn JH, Ziv Y, Newman LS, Darnell RB, Shiloh Y, Kastan MB (1998) ATM binds to beta-adaptin in cytoplasmic vesicles. Proc Natl Acad Sci USA 95:10146–10151

    Article  CAS  Google Scholar 

  14. Mitoma H, Hadjivassiliou M, Honnorat J (2015) Guidelines for treatment of immune-mediated cerebellar ataxias. Cerebellum Ataxias 2:14

    Article  Google Scholar 

  15. Mitoma H, Manto M, Hampe CS (2019) Immune-mediated cerebellar ataxias: practical guidelines and therapeutic challenges. Curr Neuropharmacol 17:33–58

    Article  CAS  Google Scholar 

  16. Newman LS, McKeever MO, Okano HJ, Darnell RB (1995) Beta-NAP, a cerebellar degeneration antigen, is a neuron-specific vesicle coat protein. Cell 82:773–783

    Article  CAS  Google Scholar 

  17. Shaw PJ, Walls TJ, Newman PK, Cleland PG, Cartlidge NE (1991) Hashimoto’s encephalopathy: a steroid-responsive disorder associated with high anti-thyroid antibody titers–report of 5 cases. Neurology 41:228–233

    Article  CAS  Google Scholar 

  18. Weihua Z, Haitao R, Fang F, Xunzhe Y, Jing W, Hongzhi G (2019) Neurochondrin antibody serum positivity in three cases of autoimmune cerebellar ataxia. Cerebellum 18:1137–1142

    Article  Google Scholar 

  19. Xu X, Ren H, Li L, Wang J, Fechner K, Guan H (2019) Anti-Homer-3 antibody associated cerebellar ataxia: a rare case report and literature review. J Neuroimmunol 330:155–158

    Article  CAS  Google Scholar 

  20. Zis P, Rao DG, Hoggard N, Sarrigiannis PG, Hadjivassiliou M (2018) Anti-MAG associated cerebellar ataxia and response to rituximab. J Neurol 265:115–118

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Guan Hongzhi.

Ethics declarations

Conflicts of interest

The author declares that there is no conflict of interest.

Ethical approval

This study was approved by the Ethics Committee of Peking Union Medical College Hospital (JS-891).

Informed consent

All included patients or their deputies provided written informed consent.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (RAR 6630 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mange, L., Haitao, R., Lixin, Z. et al. Cerebellar ataxia and myeloradiculopathy associated with AP3B2 antibody: a case report and literature review. J Neurol 268, 4163–4169 (2021). https://doi.org/10.1007/s00415-021-10496-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-021-10496-8

Keywords

Navigation